Introduction
The enzyme 1 5-lipoxygenase (I 5-LO)' catalyzes the insertion of molecular oxygen into arachidonic acid at carbon 15. The enzyme can also oxygenate other polyenoic free fatty acids as well as a variety of phospholipids (1) . This ability to perform lipid peroxidation is evident in multiple biological systems. For example, 1 5-LO activity has been identified by enzymatic assays in rabbit and human reticulocytes (2, 3) , in human leukocytes (4) (5) (6) , in human lung (7) , and in human airway epithelial cells (8) . In the reticulocyte, the enzyme is believed to contribute to differentiation ofthat cell into a mature erythrocyte. The mechanism of action is presumably the hydroperoxidation of intracellular membranes that are then further degraded via proteolysis (2, 9) . In airway cells and in leukocytes, 1 5 -LO is believed to act via the metabolism ofarachidonic acid, thereby generating potent inflammatory mediators which have effects on various tissues in the airways (10) (11) (12) (13) (14) .
These potential biological actions of 1 5-LO have led to an increasing interest in understanding the biochemical mechanism of the enzyme. The mammalian form of the enzyme has been purified to homogeneity from rabbit reticulocytes (2) and from human leukocytes (15) . Using protein sequence from the mammalian enzymes, we recently isolated a cDNA encoding 1 5-LO from a human reticulocyte library (16) . This cDNA has now been expressed in active form in both eukaryotic and prokaryotic cells, verifying its authenticity (17) .
The precise localization of 1 5-LO in blood cells and in lung has not yet been defined. Prior studies using enzymatic activity have failed to accomplish this because they have been limited in their ability to detect the expression of the enzyme on a cellular level. Tissue localization of 1 5-LO has the potential to yield important information regarding the expression of the enzyme and regarding additional biological roles ofthe enzyme within a given cell type or tissue. Bacterial expression ofrecombinant 1 5-LO has allowed us to obtain sufficient quantities of recombinant enzyme to develop a polyclonal antibody to human reticulocyte 15-LO (17) and to study its immunocytochemical localization in human leukocytes and airways and in rabbit red blood cells.
Methods
Preparation ofcells. Human osteosarcoma (OS) cells were transfected with a mammalian expression vector containing the cDNA for human reticulocyte 15-LO as previously described (17) . This cell line, OS 1 5LOX(+), has been shown to express 1 5-LO by enzymatic activity and by immunoreactivity (17) . The cell line OS I 5LOX(-) was created by transfecting osteosarcoma cells with the same mammalian expression vector but without the 1 5-LO cDNA and was used in this study to assess baseline immunofluorescence in osteosarcoma cells.
In preliminary studies, we found that normal human red blood cells did not show 1 5-LO immunofluorescence. Similarly, blood from nonanemic rabbits showed no 1 5-LO immunofluorescence. Therefore, we bled three rabbits intermittently (30-50 ml/bleed) for up to 15 d. After day 7 ofbleeding, the anemia was stable (hematocrit, 20-25%; reticulocyte count, > 25%). In the first rabbit, we studied the peripheral blood on day 6 of bleeding, and we compared 15-LO fluorescence to that obtained in red blood cells removed on day 1. In the second rabbit, we characterized the time course of 1 5-LO fluorescence in relation to the evolution ofthe anemia. In the third rabbit, specimens ofvenous blood were removed on days 10 and 15 of bleeding, and samples of blood were separated into four fractions by a method previously described (18) , which separates red blood cells according to their state of maturation. In these four fractions, we studied cell morphology and 15-LO fluorescence. All blood smears were fixed with methanol or cold acetone for immunofluorescence.
Human leukocytes were obtained from anticoagulated venous blood samples from two normal volunteers and from four hypereosinophilic patients. Leukocytes were separated by dextran sedimentation, followed by hypotonic lysis of the red blood cells. Cytospin preparations ofthe buffy coat were fixed in methanol. Various leukocyte types were identified by phase microscopy of blood smears and then were compared for the presence of 1 5-LO by fluorescent microscopy. Neutrophils and eosinophils were further separated from mononuclear cells by Ficoll-Paque or Percoll gradients (19) and were analyzed for both 1 5-LO activity and immunofluorescence. Differential cell counts on 200 cells were obtained from blood smears after Diff-Quik staining (Dade Diagnostics, Aguada, Puerto Rico).
Human airway epithelial cells were examined in three ways. First, we obtained airway epithelial cells from scrapings of the mucosa from two tracheas postmortem. Second, human airway epithelial cells (> 95% purity) were isolated from a human trachea obtained < 24 h postmortem by a method of enzymatic digestion (20) . Aliquots of all isolated cells were cytocentrifuged and fixed for immunofluorescence with methanol. Third, we obtained bronchial tissue from one patient at the time of lung resection and tracheal tissue from two patients postmortem. Human Antibody to human 15-lipoxygenase. A previously characterized rabbit polyclonal antibody to recombinant human reticulocyte 15-LO was used in this study (17) . In brief, the cDNA for 15-LO was subcloned into a bacterial expression vector and was expressed as a fusion with the CheY protein. The overexpressed protein was purified from bacteria and injected into rabbits. This recombinant protein was also used to test whether positive immunofluorescence could be inhibited selectively. The antibody to this recombinant material was purified by affinity chromatography (Sepharose-G, Pharmacia Fine Chemicals, Piscataway, NJ) and was shown to specifically react on immunoblots to one major band of the expected molecular size (70,000 D) for 15-LO from human leukocytes, human tracheal epithelial cells, and rabbit reticulocytes ( 17) . It did not cross-react with purified 5-LO ( 17) or to highly enriched preparations of platelet 12-LO (Sigal, E., unpublished observations).
Immunofluorescence staining. Immunocytochemistry was performed at room temperature in a humidified chamber. Cells and tissues were first rinsed with PBS and were incubated with an excess of BSA or host serum for 30 min to inhibit nonspecific staining. Appropriate dilutions of the polyclonal 1 5-LO antibody were incubated on the tissue sections for I h and then rinsed extensively with PBS to eliminate unbound antibody. The sections were then exposed for 30 min to a second antibody conjugated with fluorescein isothiocyanate and were again washed to remove the unbound fluorescent tracer. Sections were coated with the fluorescent enhancer DABco and were viewed under a Zeiss Axioplan fluorescent microscope. For the study of eosinophils, an additional step was included to prevent nonspecific staining, as described elsewhere (21): After exposure to the primary antibody, eosinophils were further incubated with a 1% chromotrope 2R solution at 37°C for 30 min. After extensive washes, the tissue sections were treated in the same fashion as above.
Assay ofi5-lipoxygenase activity. Cellular capacity for oxygenation of exogenous substrate was tested by incubating cells with arachidonic acid dissolved in ethanol (0.5%). Final concentrations of -5 X 106 cells/ml were incubated with substrate (160 ,uM) for 15 min at 37°C. In some experiments, broken cell preparations were prepared by sonication as described elsewhere (15) . Cell suspensions were extracted with 1 vol of 2-propanol containing 1.2% acetic acid (vol/vol) (pH 3.5) and I vol of chloroform. An aliquot ofprostaglandin B2 was used as an internal standard. All extracts were washed with water and were reconstituted in methanol for storage at -70'C under N2. Reagents were incubated with cell-free media to assess nonenzymatic generation of products. Extracts were reconstituted in chromatography solvent and were analyzed by reverse-phase (RP) HPLC on a model 840 chromatography system (Waters Chromatography Division, Milford, MA) using a Dynamax C-18 column (5 gm, 4.6 mm X 25 cm, Rainin, Instrument Co., Inc., Emeryville, CA) as previously described (17) .
Results
We established conditions for immunofluorescent staining of mammalian tissues by studying the human osteosarcoma cell line, OS1 5LOX(+). Transfection ofthese cells with a mammalian expression plasmid containing the cDNA for human reticulocyte 1 (Fig. 1, left) . The number of reticulocytes with positive fluorescence increased progressively to day 8 (Fig. 1, middle) and then gradually decreased. Thus, although the number of reticulocytes remained constant from day 8 to 13, both the number of reticulocytes that fluoresced and the degree of fluorescence had decreased by day 13 (Fig. 1,  right) . These studies indicate that 15-LO expression changes during the differentiation of reticulocytes.
In the third rabbit, we obtained blood samples on days 10 and 15, and we separated the cells by buoyant density, a method previously described for separating red blood cells according to their state of maturation (Fig. 2) (18) . The first fraction, containing early reticulocytes, showed little fluorescence. Human eosinophils. It is clear that eosinophils have an active 15-LO (4), but it is not clear whether other granulocytes such as neutrophils express 1 5-LO. Therefore, in two normal and in four hypereosinophilic patients, we obtained blood, concentrated the leukocytes, prepared blood smears, and examined them microscopically. Monocytes, lymphocytes, and neutrophils were identifiable on phase microscopy ( Fig. 3, left) and did not exhibit 1 5-LO immunofluorescence (Fig. 3, right) . Eosinophils were also identifiable by the typical morphology of the nucleus and the large refractile granules (Fig. 3, left) ; only eosinophils exhibited 15-LO immunofluorescence (Fig. 3,  right) .
In each of the six subjects, we further isolated neutrophils and eosinophils from other leukocytes on gradients, prepared smears ofthe cells, and examined them for percent neutrophils vs. eosinophils and for 15-LO immunofluorescence. Separate aliquots of cells were incubated with arachidonic acid, and 15-LO activity was subsequently assessed (Table I ). In the two specimens containing < 1% eosinophils, no 15-LO products were detected. Only blood containing eosinophils was capable of generating 1 5-LO products. When the values of these products were normalized for the numbers of eosinophils present, the values for production of 15-LO were similar among subjects (Table I) .
Only eosinophils showed 15-LO immunofluorescence. In each case, the fluorescence was localized to the cytoplasm and excluded the nucleus and the cytoplasmic granules. The immunofluorescence was quenched by recombinant 15-LO. In the two subjects who showed no 15-LO activity, no eosinophils were found in the blood smears, and no 1 5-LO immunofluorescence was present. Human airways. We examined human airways by three methods: epithelial cells recovered from scrapings obtained postmortem, epithelial cells dissociated from postmortem tracheas, and whole sections ofhuman airways (trachea and bronchi) obtained postmortem. In specimens of airway epithelium obtained from tracheas postmortem by scraping, both ciliated and basal cells were identified by phase microscopy (Fig. 4,  upper panels) . No goblet cells were found. Both ciliated (Fig. 4 , lower panels) and basal cells showed fluorescent staining ofthe cytoplasm and exclusion ofthe nucleus, with marked variation in intensity ofstaining among cells. Fluorescence was inhibited selectively with the addition of 1 clear that eosinophils have an active 15-LO (4), it has been much less clear whether other granulocytes, particularly neutrophils, express 1 5-LO. The current study presents evidence that 1 5-LO is a cytosolic enzyme which is highly tissue-specific and which is expressed variably from cell to cell in a given tissue. Among red blood cells, 15-LO is expressed at certain stages of reticulocyte differentiation. In leukocytes there is only expression in eosinophils. Within human airway, the expression of 1 5-LO is localized to the airway epithelium, with variable expression among epithelial cells.
Investigators of the reticulocyte 1 5-LO have presented evidence from enzyme activity and immunoblots suggesting that the red blood cell enzyme is cell-specific (2, 3). Our study presents immunological evidence that the 1 5-LO of reticulocytes, eosinophils, and the airway epithelium are related. This is supported by immunoblots on crude preparations reported previously (17) . Although the reason that prior studies concluded that the red blood cell enzyme is unique to that cell may be due in part to species differences, it is also possible that the screening assays used were not sensitive enough to detect low levels ofspecific tissue expression. Hence, assays on whole lung could potentially miss airway epithelial 1 5-LO expression and similarly, assays on leukocytes that are not enriched with eosinophils may not detect enzyme expression.
The 1 5-LO is believed to play a major role in the differentiation of the reticulocyte into a mature erythrocyte because the enzyme is selectively able to degrade, through lipid peroxidation, the mitochondria that that cell must rid itself of to become a specialized red cell (2, 9) . We have observed a correlation of 15-LO fluorescence with reticulocyte differentiation showing that fluorescence was limited to developing red cells and was not detected in mature cells. Importantly, not all reticulocytes of all ages (as judged by buoyant density) expressed 15-LO. Large, young reticulocytes did not express 15-LO. A greater percentage of maturing reticulocytes exhibited fluorescence than did younger reticulocytes. In addition, 1 5-LO was diminished in late reticulocytes and was absent from mature red blood cells. These findings suggest that the enzyme is induced at some stage during the later phase of reticulocyte differentiation and is turned off completely at the stage of a mature red cell. This is entirely consistent with the studies on reticulocyte maturation performed in vivo (2, 9) . Although the current study was not designed to monitor the appearance of 1 5-LO during the cellular events that occur during reticulocyte maturation, it is evident that in vitro and in vivo systems can be designed to do so and that the immunofluorescent detection of 15-LO should prove invaluable in correlating the role of the enzyme in these events.
Our results suggest that among leukocytes there is a preferential expression of 15-LO in eosinophils. In particular, there appears to be no evidence for neutrophil expression of 1 5-LO. Neutrophil fractions that contain eosinophils have activity that can be accounted for by the accompanying eosinophils, and the fluorescence in these fractions is localized to the eosinophils. This finding of preferential expression of 1 5-LO in eosinophils might appear to contrast with prior studies on leukocyte 1 5-LO in which the predominant cell type was the neutrophil (5, (22) (23) (24) . However, these prior studies did not report the percentage of contaminating eosinophils nor was the cell source among leukocytes a focus ofthese studies. The original studies on leu-kocyte 1 5-LO by Turk et al. made the point that 1 5-LO activity correlated with the percentage of eosinophils in mixed leukocyte preparations (4) . The amount of 1 5-LO activity determined by these investigators and confirmed by later studies in our group (6) can readily explain the levels of 1 5-LO activity reported in mixed leukocyte preparations. For example, 15-hydroxyicosatetraenoic acid (HETE) formation from eosinophils can be as high as 1,000 ng/106 cells (4, 6, 25) . Therefore, a leukocyte preparation of 2 X IO' cells containing 4-8% eosinophils, which is within normal range after mononuclear cells are removed, can produce up to 1,600 ng of 15-HETE. This amount of 1 5-HETE from the contaminating eosinophils can exceed the amount of 5-HETE generated from the accompanying, more abundant, neutrophils.
Conditions of maximal stimulation of 15-HETE involve cytotoxic doses of arachidonic acid, and this may account for the speculation that cell death activates 1 5-LO (23). We considered the possibility that sonicated cell preparations of neutrophils might "unmask" 15-LO activity, but such preparations (> 99% neutrophils) failed to produce 15-LO products (data not shown). Furthermore, RNA blots using the 1 5-LO cDNA do not identify 1 
